Contineum Therapeutics, Inc. (a Delaware corporation) [•] Shares of Class A Common Stock Underwriting AgreementUnderwriting Agreement • April 1st, 2024 • Contineum Therapeutics, Inc. • Pharmaceutical preparations
Contineum Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [•] shares (the “Firm Shares”) and, at the election of the Underwriters, up to [•] additional shares (the “Optional Shares”) of Class A Common Stock, par value $0.001 per share (“Stock”), of the Company (the Firm Shares and the Optional Shares that the Underwriters elect to purchase pursuant to Section 2 hereof being collectively called the “Shares”).
AMENDED AND RESTATED]1 INDEMNITY AGREEMENTIndemnity Agreement • April 1st, 2024 • Contineum Therapeutics, Inc. • Pharmaceutical preparations • California
THIS [AMENDED AND RESTATED] INDEMNITY AGREEMENT (this “Agreement”) dated as of ________________, is made by and between Contineum Therapeutics, Inc., a Delaware corporation (the “Company”), and _____________ (“Indemnitee”).
